These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37140504)

  • 1. Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Interstitial Brachytherapy Is Safe: First Results From the Tri-fraction Radiation Therapy Used to Minimize Patient Hospital Trips (TRIUMPH-T) Trial.
    Yashar C; Khan AJ; Chen P; Einck J; Poppe M; Li L; Yehia ZA; Vicini FA; Moore D; Arthur D; Quinn TJ; Kowzun M; Simon L; Scanderbeg D; Shah C; Haffty BG; Kuske R
    Pract Radiat Oncol; 2023; 13(4):314-320. PubMed ID: 37140504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T Trial.
    Khan AJ; Chen PY; Yashar C; Poppe MM; Li L; Abou Yehia Z; Vicini FA; Moore D; Dale R; Arthur D; Shah C; Haffty BG; Kuske R
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):67-74. PubMed ID: 30611839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
    Vicini FA; Cecchini RS; White JR; Arthur DW; Julian TB; Rabinovitch RA; Kuske RR; Ganz PA; Parda DS; Scheier MF; Winter KA; Paik S; Kuerer HM; Vallow LA; Pierce LJ; Mamounas EP; McCormick B; Costantino JP; Bear HD; Germain I; Gustafson G; Grossheim L; Petersen IA; Hudes RS; Curran WJ; Bryant JL; Wolmark N
    Lancet; 2019 Dec; 394(10215):2155-2164. PubMed ID: 31813636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: Results of a prospective single-institutional registry.
    Gabani P; Cyr AE; Zoberi JE; Ochoa LL; Matesa MA; Thomas MA; Garcia J; Margenthaler JA; Naughton MJ; Ma C; Sanati S; Zoberi I
    Brachytherapy; 2018; 17(1):171-180. PubMed ID: 29089275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial.
    Strnad V; Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Łyczek J; Guinot JL; Gutierrez Miguelez C; Slampa P; Allgäuer M; Lössl K; Polat B; Fietkau R; Schlamann A; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Dunst J; Gall C; Uter W;
    Lancet Oncol; 2023 Mar; 24(3):262-272. PubMed ID: 36738756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
    Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 2 Trial of Accelerated Partial Breast Irradiation (APBI) Using Noninvasive Image Guided Breast Brachytherapy (NIBB).
    Hepel JT; Leonard KL; Sha S; Graves TA; Wiggins DL; Mastras D; Pittier A; ; Wazer DE
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1143-1149. PubMed ID: 32721422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
    Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
    Whelan TJ; Julian JA; Berrang TS; Kim DH; Germain I; Nichol AM; Akra M; Lavertu S; Germain F; Fyles A; Trotter T; Perera FE; Balkwill S; Chafe S; McGowan T; Muanza T; Beckham WA; Chua BH; Gu CS; Levine MN; Olivotto IA;
    Lancet; 2019 Dec; 394(10215):2165-2172. PubMed ID: 31813635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five fraction accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy: Feasibility and acute toxicity.
    Hepel JT; Yashar C; Leonard KL; Einck JP; Sha S; DiPetrillo T; Wiggins D; Graves TA; Edmonson D; ; Wazer DE
    Brachytherapy; 2018; 17(5):825-830. PubMed ID: 29936130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single-Institution Retrospective Study of Three-Fraction HDR Accelerated Partial Breast Irradiation.
    Chung EM; Nguyen AT; Mirhadi A; Steers JM; Phillips T; Atkins KM; Burnison M; Shiao SL; Kamrava M
    Brachytherapy; 2023; 22(3):361-367. PubMed ID: 36997449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial.
    Hattangadi JA; Powell SN; MacDonald SM; Mauceri T; Ancukiewicz M; Freer P; Lawenda B; Alm El-Din MA; Gadd MA; Smith BL; Taghian AG
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):791-800. PubMed ID: 22099046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity.
    Vargo JA; Verma V; Kim H; Kalash R; Heron DE; Johnson R; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):285-91. PubMed ID: 24268787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
    Benitez PR; Chen PY; Vicini FA; Wallace M; Kestin L; Edmundson G; Gustafson G; Martinez A
    Am J Surg; 2004 Oct; 188(4):355-64. PubMed ID: 15474426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using multicatheter interstitial brachytherapy: clinical results with a median follow-up of 60 months.
    Yoshida K; Nose T; Otani Y; Asahi S; Tsukiyama I; Dokiya T; Saeki T; Fukuda I; Sekine H; Kumazaki Y; Takahashi T; Kotsuma T; Masuda N; Yoden E; Nakashima K; Matsumura T; Nakagawa S; Tachiiri S; Moriguchi Y; Itami J; Oguchi M
    Breast Cancer; 2022 Jul; 29(4):636-644. PubMed ID: 35303282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.
    Schäfer R; Strnad V; Polgár C; Uter W; Hildebrandt G; Ott OJ; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Gall C; Polat B;
    Lancet Oncol; 2018 Jun; 19(6):834-844. PubMed ID: 29695348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.